Skip to main content
博迅生物 logo

博迅生物 — Investor Relations & Filings

Ticker · 920504 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 301 across all filing types
Latest filing 2024-10-16 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920504

About 博迅生物

http://www.boxun.com.cn/

Boxun Medical Biological Instrument Corp. specializes in the development and manufacture of laboratory equipment and medical instruments. The company's core product line includes high-pressure steam sterilizers, constant temperature incubators, CO2 incubators, drying ovens, and environmental test chambers. These instruments are designed for applications in life sciences, healthcare, pharmaceutical research, and environmental monitoring. Boxun focuses on delivering precise thermal control and reliable sterilization solutions, ensuring compliance with international quality standards. Its equipment is utilized in scientific research, clinical diagnostics, and industrial quality control to maintain sterile environments and stable experimental conditions. The company emphasizes technical innovation and product durability to support the requirements of modern laboratory facilities.

Recent filings

Filing Released Lang Actions
关于收到政府补助的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the receipt of government subsidies by the company Shanghai BoXun Medical Biological Instruments Co., Ltd. It includes details about the amount received, the accounting treatment, and a legal disclaimer by the board. The document is only 533 characters long and does not contain any financial statements or detailed financial data. It is an announcement of a specific event (government subsidy receipt) rather than a full financial report or audit. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-10-16 Chinese
2024年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2024 first extraordinary shareholders meeting of Shanghai Boxun Medical Biological Instruments Co., Ltd. It includes information about the meeting's convening, attendance, agenda items, voting results on board and supervisory committee elections, and other shareholder proposals. It also contains legal opinions on the meeting's validity. The document is not a full annual or interim report, nor a financial statement or earnings release. It is not a proxy solicitation or investor presentation. It is a formal announcement of voting results and decisions made at a shareholders meeting, including board and supervisory changes. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 4317 characters, which is sufficient for a detailed voting results announcement rather than a brief notice or a report publication announcement.
2024-10-13 Chinese
2024年第一次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, attendance, voting procedures, and results of a company's 2024 first extraordinary general meeting (临时股东大会). It details the legality and validity of the meeting process and the election of board members and supervisors. The document does not contain financial statements or performance data but focuses on the procedural and legal aspects of the shareholder meeting and voting results. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA), which covers official results from shareholder votes at any general meeting. The document length is under 5,000 characters, but it contains detailed voting results and legal validation, so it is not merely an announcement of a report but the voting results themselves. Therefore, the correct classification is DVA.
2024-10-13 Chinese
股票解除限售公告
Share Issue/Capital Change Classification · 95% confidence The document is a stock unlocking announcement from Shanghai Boxun Medical Biological Instruments Co., Ltd. It details the number of shares being unlocked from trading restrictions, the shareholders involved, reasons for unlocking, and the updated share capital structure. It does not contain financial statements, earnings data, or management discussion. It is not an annual or interim report, nor a call transcript or capital update. The document is a regulatory announcement about share unlocking, which fits best under the category of Share Issue/Capital Change (SHA) as it relates to changes in share capital availability and trading status.
2024-10-13 Chinese
关于使用闲置自有资金购买理财产品的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Shanghai Boxun Medical Biological Instruments Co., Ltd. regarding the progress of using idle proprietary funds to purchase financial products. It details the amounts, types, counterparties, and risk controls related to these financial investments. The document includes tables of current and matured financial products, risk warnings, and internal control measures. It is a disclosure about capital management activities, specifically the use of idle funds for financial products, and does not contain financial statements or earnings data. It is not a full financial report, earnings release, or management discussion. The document is a regulatory disclosure about capital usage and investment activities, fitting the category of Capital/Financing Update (CAP). The document length is 4247 characters, which is sufficient for a detailed announcement but not a full report. Therefore, the appropriate classification is CAP with high confidence.
2024-09-26 Chinese
独立董事提名人声明（代彦军）
Board/Management Information Classification · 95% confidence The document is a nomination statement and commitment declaration for an independent director candidate at Shanghai BoXun Medical Biological Instruments Co., Ltd. It details the qualifications, legal compliance, and independence criteria for the nominee, along with assurances of truthfulness and completeness. There are no financial statements, earnings data, or report attachments. The content is focused on board/management information, specifically the nomination of a board member. The document length is 2532 characters, which is relatively short and consistent with a management or board announcement rather than a full report. Therefore, the appropriate classification is Board/Management Information (MANG).
2024-09-24 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.